Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEXGEL
Langhorne, Pennsylvania, United Statesnexgel.com ↗
- Ownership
- Public · NXGL
- Development stage
- Other
01
Overview
NEXGEL has over two decades of experience developing and manufacturing proprietary electron-beam cross-linked hydrogels for healthcare and consumer applications. Their products are commercialized both as contract manufactured components for third parties and under their own brands in OTC wound care, pain relief, beauty/cosmetics, and podiatry. The company operates a cGMP FDA registered facility in Pennsylvania[1][2][3][4].
- Therapeutic areas
- OtherDermatology
- Modalities
- Hydrogel-based drug delivery therapyDevice
- Industry
- Consumable Medical Devices
02
Partnerships
Strategic partners in medical device OEMs and consumer brands
03
Financials
- Market cap
- $2M
- Total revenue
- $11.4M
- Enterprise value
- $9M
Beyond the preview
Go deeper on NEXGEL.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NEXGEL.